Key facts
- Morimatsu Pharmaceutical Equipment’s last known valuation is $352.4M (Jul 2025).
- It has raised $46.0M; the latest was Later Stage VC ($46.0M) in Jul 2025.
- Notable investors include Suzhou Asset Management, CICC Private Equity.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Morimatsu Pharmaceutical Equipment
- ·The full record, as it builds
Funding rounds
No funding rounds for Morimatsu Pharmaceutical Equipment are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Morimatsu Pharmaceutical Equipment
Provider of core equipment, process systems and digitalized total factory solutions for pharmaceutical, biopharmaceutical, FMCG, cosmetic and e-chemical industries. The company's products include bioreactors, fermenter systems, tangential flow filtration systems, in-line dispensing systems, wet granulators, multi-functional fluidized beds, WD multi-functional filtration and washing dryers (three-in-one), sanitary containers, and heat exchangers.
- Sector
- Business Products and Services (B2B)
- HQ
- Shanghai, China
- Founded
- 2001
- Ownership
- Privately Held (backing)
Morimatsu Pharmaceutical Equipment doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Morimatsu Pharmaceutical Equipment shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Morimatsu Pharmaceutical Equipment in its N-PORT filings yet. We sweep new filings monthly.